Patient presents for evaluation of liver function due to [reason for testing; e.g., abnormal liver enzymes on routine bloodwork, fatigue, abdominal pain, jaundice, suspected liver disease].  A comprehensive metabolic panel (CMP) and hepatic function panel (also known as liver function tests or LFTs) were ordered to assess liver health and identify potential underlying etiologies.  The hepatic panel includes tests for albumin, total protein, alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin (total and direct), and gamma-glutamyl transferase (GGT).  Results of the hepatic panel reveal [specific results; e.g., elevated ALT and AST, normal ALP, mildly elevated bilirubin, indicating possible hepatocellular injury].  Differential diagnoses include viral hepatitis, non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, drug-induced liver injury, autoimmune hepatitis, and other less common liver disorders.  Patient's medical history includes [relevant medical history; e.g., type 2 diabetes, hyperlipidemia, no history of alcohol abuse]. Current medications include [list medications].  Physical examination findings include [relevant physical exam findings; e.g., normal abdominal exam, no hepatomegaly or splenomegaly, no jaundice].  Based on the patient's presentation, laboratory findings, and medical history, the preliminary diagnosis is [preliminary diagnosis; e.g., suspected NAFLD].  Further investigation with [further tests; e.g., hepatitis panel, liver ultrasound, consultation with gastroenterology] is recommended to confirm the diagnosis and guide treatment.  Patient education provided on liver health, lifestyle modifications including diet and exercise, and the importance of follow-up care.  ICD-10 code[s] [insert relevant ICD-10 code(s); e.g., K76.0] assigned.  CPT code[s] for the hepatic function panel [insert relevant CPT code(s); e.g., 80076] documented for billing purposes.